Continuous Glucose Monitoring Is Associated with Lower Risk of Diabetic Retinopathy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Continuous glucose monitoring (CGM) in adults with type 1 diabetes may reduce the risk of developing diabetic retinopathy. However, CGM and insulin pump use did not show associations with the progression of this eye condition.
Area Of Science
- Ophthalmology
- Endocrinology
- Diabetes Management
Background
- Diabetic retinopathy is a leading cause of vision loss in adults with type 1 diabetes.
- Effective management of type 1 diabetes is crucial to prevent microvascular complications.
- Continuous glucose monitoring (CGM) offers advanced insights into glycemic control.
Purpose Of The Study
- To investigate the association between continuous glucose monitoring (CGM) use and the incidence of diabetic retinopathy.
- To examine the relationship between CGM, insulin pump use, and the progression of diabetic retinopathy in adults with type 1 diabetes.
Main Methods
- Retrospective cohort study analyzing data from adult patients with type 1 diabetes.
- Comparison of diabetic retinopathy development and progression between users and non-users of CGM and insulin pumps.
Main Results
- Continuous glucose monitoring (CGM) use was associated with lower odds of developing diabetic retinopathy.
- CGM use was also linked to reduced odds of developing proliferative diabetic retinopathy.
- No significant associations were found between CGM use, insulin pump use, or combined use, and the progression of diabetic retinopathy.
Conclusions
- Continuous glucose monitoring (CGM) may play a protective role in preventing the onset of diabetic retinopathy in type 1 diabetes.
- Further research is needed to understand the impact of CGM and insulin pump therapy on diabetic retinopathy progression.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...